BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7517763)

  • 21. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
    Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa.
    Irazusta SP; Vassallo J; Magna LA; Metze K; Trevisan M
    Pathol Res Pract; 1998; 194(1):33-9. PubMed ID: 9542745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
    Mukherjee J; Misra V; Gupta SC; Gupta AK; Tandon SP
    Urol Int; 1997; 58(2):75-9. PubMed ID: 9096266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
    Smith FG; Murray PG; Crocker J
    J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AgNOR staining in benign hyperplasia and carcinoma of the prostate.
    Mamaeva S; Lundgren R; Elfving P; Limon J; Mandahl N; Mamaev N; Henrikson H; Heim S; Mitelman F
    Prostate; 1991; 18(2):155-62. PubMed ID: 1706512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
    Mourad WA; Sneige N; Katz RL; Ordóñez NG
    Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
    Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining.
    Miyazaki S; Sasano H; Suzuki T; Sawai T; Nishihira T; Mori S
    Mod Pathol; 1992 Jul; 5(4):396-401. PubMed ID: 1353881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
    Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
    Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.
    Pich A; Chiusa L; Pisani P; Krengli M; Pia F; Navone R
    J Cancer Res Clin Oncol; 1992; 119(2):106-10. PubMed ID: 1358893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argyrophilic nucleolar organizer regions in colorectal malignancy: application of typing by their density.
    Iwashita T; Mori H; Ito Y; Obashi A; Sugimoto K; Tei H; Hirata I; Oshiba S
    Pathol Int; 1996 Mar; 46(3):204-10. PubMed ID: 10846571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
    Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
    Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
    Kakeji Y; Maehara Y; Adachi Y; Baba H; Mori M; Furusawa M; Sugimachi K
    Br J Cancer; 1994 Apr; 69(4):749-53. PubMed ID: 7908217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silver staining nucleolar organizer region in prostate cytology.
    Bittinger A; von Keitz A; Rüschoff J; Melekos MD
    Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland.
    Zaczek M; Szot W; Chłap Z
    Anal Quant Cytol Histol; 1996 Feb; 18(1):1-8. PubMed ID: 8851102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens.
    Centeno BA; Louis DN; Kupsky WJ; Preffer FI; Sobel RA
    Am J Clin Pathol; 1993 Dec; 100(6):690-6. PubMed ID: 7902669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
    Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
    J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.